# Combined THC and CBD Drops for Treatment of Crohn's Disease

> **NCT01826188** · PHASE1,PHASE2 · COMPLETED · sponsor: **Meir Medical Center** · enrollment: 50 (actual)

## Conditions studied

- Crohn's Disease

## Interventions

- **DRUG:** THC 5mg/ml and CBS 50mg/ml
- **DRUG:** Placebo

## Key facts

- **NCT ID:** NCT01826188
- **Lead sponsor:** Meir Medical Center
- **Sponsor class:** OTHER
- **Phase:** PHASE1,PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2013-03
- **Primary completion:** 2018-06
- **Final completion:** 2018-06
- **Target enrollment:** 50 (ACTUAL)
- **Last updated:** 2019-03-08


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01826188

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01826188, "Combined THC and CBD Drops for Treatment of Crohn's Disease". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT01826188. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*